Translate this page into:
Inflammatory Myofibroblastic Tumor: Findings on 68Ga-DOTA-NOC Positron-emission Tomography-Computed Tomography
Address for correspondence: Dr. Shamim Ahmed Shamim, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi - 110 029, India. E-mail: sashamim2002@yahoo.co.in
-
Received: ,
Accepted: ,
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Inflammatory myofibroblastic tumor (IMT) or inflammatory pseudotumors are a rare group of tumors usually affecting children and young adults. They occur in various anatomic locations, with most common being the lung accounting for almost 95% of the cases. We present a case of a 4-year-old girl who presented with fever and dull abdominal pain for 6 months with a clinically palpable left hypochondrium mass. On suspicion of mesenteric/gastric neuroendocrine tumor, 68Ga-DOTA-NOC positron-emission tomography-computed tomography was done; however, the biopsy revealed IMT.
Keywords
68Ga
DOTA-NOC
inflammatory myofibroblastic tumor
positron-emission tomography-computed tomography
A 4-year-old female presented with dull aching abdominal pain and fever for 6 months to the surgical outpatient department. Per abdominal examination revealed a palpable left hypochondrium mass. Contrast-enhanced computed tomography abdomen was done which revealed lobulated and peripherally enhancing mass measuring approximately 6.6 cm × 6.3 cm × 5 cm in the stomach bed region, likely arising from the greater curvature of the stomach or from the mesentery. On suspicion of neuroendocrine tumor by the concerned clinician, the patient was referred for 68Ga-DOTANOC positron-emission tomography-computed tomography (PET-CT) to look for any additional sites of metastases. 68Ga-DOTA-NOC PET-CT maximum intensity projection image shows increased radiotracer uptake in the abdomen region on the left side [Figure 1a, solid black arrow] which corresponds to a lobulated mass in the gastric bed region with areas of internal necrosis and calcification on axial and coronal CT images [Figure 1b and e, solid white arrows] showing increased DOTA-NOC uptake in the PET only [Figure 1c and f] and fused PET-CT images [Figure 1d and g]. Ultrasound-guided biopsy from the left hypochondrium mass showed spindle cell tumor with tumor cells arranged in fascicles, which were infiltrating at places and were embedded in a collagenous background. Immunohistochemistry showed cytoplasmic positivity for smooth muscle actin, desmin, and anaplastic lymphoma kinase-1 and negative for CD117, DOG-1, and myogenin. The overall feature was suggestive of inflammatory myofibroblastic tumor (IMT). The patient underwent surgery after the PET-CT scan as no distant metastasis was present, and the histopathology of the surgical specimen was suggestive of IMT. IMT is an uncommon mesenchymal tumor with an intermediate malignant neoplasm and usually presents in the children and young adults.[1] It can frequently recur and metastasize.[23] Heterogeneity in FDG uptake has been demonstrated in few of the earlier case reports likely due to variability in the population of inflammatory cells in tumor.[45678] Evidence of somatostatin receptor expression has been seldom demonstrated in IMTs and through this the authors want to undermine the fact that IMTs should also be included as a potential differential diagnosis in case of mesenteric mass on 68Ga-DOTA-NOC PET-CT apart from neuroendocrine tumors.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- Inflammatory myofibroblastic tumor of the stomach in an adult female – Report of a rare case and review of the literature. Turk J Gastroenterol. 2012;23:399-405.
- [Google Scholar]
- Inflammatory myofibroblastic tumor: Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509-20.
- [Google Scholar]
- Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859-72.
- [Google Scholar]
- Fluoro-deoxy glucose-avid endobronchial inflammatory myofibroblastic tumor mimicking bronchial malignancy: Report of a case. J Cancer Res Ther. 2011;7:340-3.
- [Google Scholar]
- Metastatic inflammatory myofibroblastic tumor imaged by PET/CT. Clin Nucl Med. 2006;31:106-8.
- [Google Scholar]
- Multiple inflammatory myofibroblastic tumors involving lung and mediastinum: A rare clinical entity. Thorac Cardiovasc Surg. 2009;57:343-6.
- [Google Scholar]
- Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation. Clin Nucl Med. 2014;39:113-21.
- [Google Scholar]
- Inflammatory myofibroblastic tumor mimicking lymphoma on 18F-FDG PET/CT. Report of a case and review of the literature. Hell J Nucl Med. 2018;21:77-80.
- [Google Scholar]